Non-ST-elevation acute coronary syndrome: The problem in elderly patients;Sindromi coronariche acute senza sopraslivellamento del tratto ST: Il problema del paziente anziano

Italian Heart Journal Supplement

Volumn 6, Issue 1, 2005, Pages 29-34

  Leoncini, Mario ^a,c   De Servi, Stefano ^b   Badia, Toni ^a   Dabizzi, Roberto Piero ^a  

^a MISERICORDIA E DOLCE HOSPITAL   (Italy)

^b Ospedale Civile   (Italy)

^c NONE   (Italy)

Author keywords

Acute coronary syndrome; Elderly

Indexed keywords

CARDIOVASCULAR RISK; CLINICAL TRIAL; COMORBIDITY; CORONARY ARTERY DISEASE; ELDERLY CARE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; MORTALITY; REVIEW; ST SEGMENT ELEVATION; AGE; AGED; ANGIOCARDIOGRAPHY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; ELECTROCARDIOGRAPHY; FOLLOW UP; HEART INFARCTION; HEART STROKE VOLUME; MIDDLE AGED; POSTOPERATIVE COMPLICATION; QUALITY OF LIFE; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TIME;

AGE FACTORS; AGED; AGED, 80 AND OVER; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; STROKE VOLUME; TIME FACTORS;

EID: 15944393896     PISSN: 11294728     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Steg PG, Goldberg RJ, Gore JM, et al, for the GRACE Investigators. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 2002; 90: 358-63.
2. De Servi S, Cavallini C, Dellavalle A, et al, for the ROSAI-2 Investigators. Non-ST-elevation acute coronary syndrome in the elderly: treatment strategies and 30-day outcome. Am Heart J 2004; 147: 830-6.
3. Januzzi JL Jr, Sabatine MS, Wan Y, Servoss SJ, DiBattiste PM, Jang IK, Theroux P. Interactions between age, outcome of acute coronary syndromes, and tirofiban therapy. Am J Cardiol 2003; 91: 457-61.
4. Hasdai D, Holmes DR Jr, Criger DA, Topol EJ, Califf RM, Harrington RA. Age and outcome after acute coronary syndromes without persistent ST-segment elevation. Am Heart J 2000; 139: 858-66.
5. Boersma E, Pieper KS, Steyerberg EW, et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation 2000; 101: 2557-67.
6. Marschner IC, Colquhoun D, Simes RJ, et al. Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. LIPID Study Investigators. J Am Coll Cardiol 2001; 38: 56-63.
7. Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000; 284: 835-42.
8. Bach RG, Cannon CP, Weintraub WS, et al. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med 2004; 141: 186-95.
9. Graham MM, Ghali WA, Faris PD, Galbraith PD, Norris CM, Knudtson ML, for the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) Investigators. Survival after coronary revascularization in the elderly. Circulation 2002; 105: 2378-84.
10. Leoncini M, Maioli M, Bellandi F, et al. Therapeutic strategies, immediate and mid-term outcomes in non-ST-segment elevation acute coronary syndromes with respect to age: a single-center registry of 488 consecutive patients. Clin Cardiol 2004; 27: 475-9.
11. Passamonti E, Pirelli S. Impatto decisionale delle patologie associate nella scelta tra strategia aggressiva e conservativa nei pazienti ottuagenari con sindrome coronarica acuta senza sopralivellamento ST. Ital Heart J Suppl 2004; 5: 855-60.
12. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during Instability in Coronary artery disease Investigators. Lancet 1999; 354: 708-15.
13. Cannon CP, Weintraub WS, Demopoulos LA, et al for the TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)-Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001; 344: 1879-87.
14. Fox KA, Poole-Wilson PA, Henderson RA, et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet 2002; 360: 743-51.
15. Lee PY, Alexander KP, Hammill BG, Pasquali SK, Peterson ED. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 2001; 286: 708-13.
16. Pfsisterer M, for the TIME Investigators. Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy. Four-year follow-up of the randomized trial of invasive versus medical therapy in elderly patients (TIME). Circulation 2004; 110: 1213-8.
17. Collet JP, Montalescot G, Lison L, et al. Percutaneous coronary intervention after subcutaneous enoxaparin pretreatment in patients with unstable angina pectoris. Circulation 2001; 103: 658-63.
18. Halon DA, Adawi S, Dobrecky-Mery I, Lewis BS. Importance of increasing age on the presentation and outcome of acute coronary syndromes in elderly patients. J Am Coll Cardiol 2004; 43: 346-52.
19. Anderson HV, Cannon CP, Stone PH, et al. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol 1995; 26: 1643-50.
20. Stone PH, Thompson B, Anderson HV, et al. Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. JAMA 1996; 275: 1104-12.
21. Forman DE, Berman AD, McCabe CH, Baim DS, Wei JY. PTCA in the elderly: the "young-old" versus the "old-old". J Am Geriatr Soc 1992; 40: 19-22.
22. Craver JM, Puskas JD, Weintraub WW, et al. 601 octogenarians undergoing cardiac surgery: outcome and comparison with younger age groups. Ann Thorac Surg 1999; 67: 1104-10.
23. Peterson ED, Jollis JG, Bebchuk JD, et al. Changes in mortality after myocardial revascularization in the elderly. The national Medicare experience. Ann Intern Med 1994; 121: 919-27.
24. Fruitman DS, MacDougall CE, Ross DB. Cardiac surgery in octogenarians: can elderly patients benefit? Quality of life after cardiac surgery. Ann Thorac Surg 1999; 68: 2129-35.
25. Ellis SG, Chew D, Chan A, Whitlow PL, Schneider JP, Topol EJ. Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy. Circulation 2002; 106: 1205-10.
26. Munoz JC, Alonso JJ, Duran JM, et al. Coronary stent implantation in patients older than 75 years of age: clinical profile and initial and long-term (3 years) outcome. Am Heart J 2002; 143: 620-6.
27. Peterson ED, Alexander KP, Malenka DJ, et al, for the American Heart Association Chronic CAD Working Group. Multicenter experience in revascularization of very elderly patients. Am Heart J 2004; 148: 486-92.
28. Macie C, Forbes L, Foster GA, Douketis JD. Dosing practices and risk factors for bleeding in patients receiving enoxaparin for the treatment of an acute coronary syndrome. Chest 2004; 125: 1616-21.
29. Ragosta M. Percutaneous coronary intervention in octogenarians and the safety of glycoprotein IIb/IIIa inhibitors. J Am Coll Cardiol 2003; 42: 433-6.
30. Peters RJ, Mehta SR, Fox KA, et al, for the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Trial Investigators. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. Circulation 2003; 108: 1682-7.
31. Karvouni E, Katritsis DG, Ioannidis JP. Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions. J Am Coll Cardiol 2003; 41: 26-32.
32. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. The EPILOG Investigators. N Engl J Med 1997; 336: 1689-97.
33. Petersen JL, Mahaffey KW, Hasselblad V, et al. Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-segment elevation acute coronary syndromes: a systematic overview. JAMA 2004; 292: 89-96.
34. Iakovou I, Dangas G, Mehran R, et al. Comparison of effect of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions on risk of hemorrhagic stroke in patients ≥ 75 years of age versus those ≤ 75 years of age. Am J Cardiol 2003; 92: 1083-6.
35. Sadeghi HM, Grines CL, Chandra HR, et al. Percutaneous coronary interventions in octogenarians: glycoprotein IIb/IIIa receptor inhibitors' safety profile. J Am Coll Cardiol 2003; 42: 428-32.
36. Piper WD, Malenka DJ, Ryan TJ, et al. Predicting vascular complications in percutaneous coronary interventions. Am Heart J 2003; 145: 1022-9.
37. Maeder M, Klein M, Fehr T, Rickli H. Contrast nephropathy: review focusing on prevention. J Am Coll Cardiol 2004; 44: 1763-71.